176 related articles for article (PubMed ID: 9625455)
1. Hyperthyroid Graves' disease and primary hypothyroidism caused by TSH receptor antibodies in monozygotic twins: case reports.
Tani J; Yoshida K; Fukazawa H; Kiso Y; Sayama N; Mori K; Aizawa Y; Hori H; Nakasato N; Abe K
Endocr J; 1998 Feb; 45(1):117-21. PubMed ID: 9625455
[TBL] [Abstract][Full Text] [Related]
2. [Significance of circulating anti-thyroid stimulating hormone (TSH) receptor antibodies in patients with autoimmune thyroid diseases--thyroid stimulation blocking antibody in patients with Graves' disease].
Fujihira T
J UOEH; 1989 Dec; 11(4):393-401. PubMed ID: 2575267
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
4. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy.
Ueta Y; Fukui H; Murakami H; Yamanouchi Y; Yamamoto R; Murao A; Santou Y; Taniguchi S; Mitani Y; Shigemasa C
Thyroid; 1999 Feb; 9(2):179-82. PubMed ID: 10090319
[TBL] [Abstract][Full Text] [Related]
5. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism.
Takasu N; Yamashiro K; Ochi Y; Sato Y; Nagata A; Komiya I; Yoshimura H
Horm Metab Res; 2001 Apr; 33(4):232-7. PubMed ID: 11383928
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa.
McLachlan SM; Rapoport B
Thyroid; 2013 Jan; 23(1):14-24. PubMed ID: 23025526
[TBL] [Abstract][Full Text] [Related]
7. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
Ochi Y; Kajita Y; Hamazu M; Nagata A
Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
[TBL] [Abstract][Full Text] [Related]
8. Clinical applications of TSH receptor antibodies in thyroid diseases.
Cho BY
J Korean Med Sci; 2002 Jun; 17(3):293-301. PubMed ID: 12068130
[TBL] [Abstract][Full Text] [Related]
9. Relationship between thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine for Graves' disease: retrospective clinical survey.
Yoshida K; Aizawa Y; Kaise N; Fukazawa H; Kiso Y; Sayama N; Mori K; Hori H; Abe K
J Endocrinol Invest; 1996 Nov; 19(10):682-6. PubMed ID: 9007700
[TBL] [Abstract][Full Text] [Related]
10. TSH-receptor antibodies in hypothyroid Graves' disease.
Konishi J; Kasagi K; Hidaka A; Takeuchi R; Iida Y; Nakamura H
Exp Clin Endocrinol; 1991 May; 97(2-3):303-7. PubMed ID: 1680728
[No Abstract] [Full Text] [Related]
11. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
Mori Y; Matoba N; Miura S; Sakai N; Taira Y
World J Surg; 1992; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
[TBL] [Abstract][Full Text] [Related]
12. Transfer of autoimmune hypothyroidism following bone marrow transplantation from a donor with Graves' disease.
Marazuela M; Steegman JL
Bone Marrow Transplant; 2000 Dec; 26(11):1217-20. PubMed ID: 11149734
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin receptor autoantibodies (TSHRAbs): epitopes, origins and clinical significance.
Kohn LD; Harii N
Autoimmunity; 2003; 36(6-7):331-7. PubMed ID: 14669940
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of anti-TSH receptor antibodies in two patients who developed spontaneous hypothyroidism after antithyroid drug therapy for hyperthyroid Graves' disease.
Kaise K; Kaise N; Yoshida K; Itagaki Y; Yamamoto M; Sakurada T; Saito S; Yoshinaga K
Tohoku J Exp Med; 1987 Jul; 152(3):269-75. PubMed ID: 3660401
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
16. [Spontaneous hypothyroidism in 4 patients with Graves-Basedow disease].
González-González A; Recio Cordova JM; Aznar Ondoño I; Del Monte Jarabo Bueno M
Endocrinol Nutr; 2009 May; 56(5):273-6. PubMed ID: 19627750
[TBL] [Abstract][Full Text] [Related]
17. Development of Graves' hyperthyroidism from primary hypothyroidism in a case of thyroid hemiagenesis.
Bando Y; Nagai Y; Ushiogi Y; Toya D; Tanaka N; Fujisawa M
Thyroid; 1999 Feb; 9(2):183-7. PubMed ID: 10090320
[TBL] [Abstract][Full Text] [Related]
18. Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-alpha therapy in patients with pre-existing thyroid disorders.
Chen FQ; Okamura K; Sato K; Kuroda T; Mizokami T; Fujikawa M; Tsuji H; Okamura S; Fujishima M
Clin Endocrinol (Oxf); 1996 Aug; 45(2):207-14. PubMed ID: 8881454
[TBL] [Abstract][Full Text] [Related]
19. Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: characteristics of epitopes for thyrotropin receptor antibodies.
Chung HK; Kim WB; Park DJ; Kohn LD; Tahara K; Cho BY
Thyroid; 1999 Apr; 9(4):393-9. PubMed ID: 10319947
[TBL] [Abstract][Full Text] [Related]
20. Role of thyroid-stimulating blocking antibody in patients who developed hypothyroidism within one year after 131I treatment for Graves' disease.
Yoshida K; Aizawa Y; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Nakazato N; Tani J; Abe K
Clin Endocrinol (Oxf); 1998 Jan; 48(1):17-22. PubMed ID: 9509063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
